Market Cap

WuXi Biologics Market Capitalization:

HK$271.11 Billion

HKD as of Jan. 1, 2023

US$34.54 Billion

business WuXi Biologics Company Profile

WuXi Biologics Main Stock Listing

show_chart HKEX: 2269

Market Capitalization History of WuXi Biologics

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $304.61 B
CSL Limited $93.24 B
Regeneron Pharmaceuticals, Inc. $79.53 B
Marinomed Biotech AG $76.72 B
Vertex Pharmaceuticals Incorporated $74.13 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of WuXi Biologics market cap

Date Market Cap YoY Change
Jan. 1, 2023 HK$271.11 B -18.27%
Jan. 1, 2022 HK$331.72 B -25.76%
Jan. 1, 2021 HK$446.79 B 229.11%
Jan. 1, 2020 HK$135.76 B 47.44%
Jan. 1, 2019 HK$92.08 B 25.26%
Jan. 1, 2018 HK$73.51 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

WuXi Biologics Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

WuXi Biologics has the following listings and related stock indices.


Stock: HKEX: 2269

Stock: FSX: 1FW1

Stock: OTC: WXIBF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.